ARTICLE | Management Tracks

Gilead BD head Bender takes top job at pediatric cancer start-up Day One

Bowers to head commercial as Canaan-incubated biotech builds out team  

September 23, 2020 5:25 PM UTC

With ex-Gilead BD head Jeremy Bender on board as CEO, Canaan-incubated pediatric cancer company Day One aims to expand its in-licensed pipeline and explore partnering opportunities with larger companies.

“My background complements both of those elements,” Bender told BioCentury, adding that his past roles gave him a bird's-eye view of oncology opportunities across industry...

BCIQ Company Profiles

Day One Biopharmaceuticals Inc.